Cara Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022
April 29 2022 - 7:00AM
Cara Therapeutics, Inc. (Nasdaq: CARA), an early
commercial-stage biopharmaceutical company leading a new treatment
paradigm to improve the lives of patients suffering from pruritus,
today announced the Company will host a conference call and live
audio webcast on Monday, May 9, 2022, at 4:30 p.m. ET to report
first quarter 2022 financial results and provide a corporate
update.
To participate in the conference call, please
dial (855) 445-2816 (domestic) or (484) 756-4300 (international)
and refer to conference ID 9296276. A live webcast of the call can
be accessed under “Events & Presentations” in the News &
Investors section of the Company’s website at
www.CaraTherapeutics.com.
An archived webcast recording will be available
on the Cara website beginning approximately two hours after the
call.
About Cara Therapeutics
Cara Therapeutics is an early commercial-stage biopharmaceutical
company leading a new treatment paradigm to improve the lives of
patients suffering from pruritus. The Company’s novel KORSUVA™
(difelikefalin) injection is the first and only FDA-approved
treatment for moderate-to-severe pruritus associated with chronic
kidney disease in adults undergoing hemodialysis. The Company is
developing an oral formulation of difelikefalin and has initiated
Phase 3 programs for the treatment of pruritus in patients with
non-dialysis dependent advanced chronic kidney disease and atopic
dermatitis. Phase 2 trials of Oral KORSUVA (difelikefalin) are
ongoing in primary biliary cholangitis and notalgia paresthetica
patients with moderate-to-severe pruritus. For more information,
visit www.CaraTherapeutics.com and follow the company on Twitter,
LinkedIn and Instagram.
MEDIA CONTACT:Annie Spinetta6
Degrees973-768-2170aspinetta@6degreespr.com
INVESTOR CONTACT:Iris Francesconi, Ph.D.Cara
Therapeutics203-406-3700investor@caratherapeutics.com
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Apr 2023 to Apr 2024